$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000143774921026507 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$2.846M	$2.108M	$1.246M
YoY Change	28.66%	69.19%	-34.41%
Cost Of Revenue	$1.066M	$748.0K	$409.6K
YoY Change	34.77%	82.61%	-21.78%
Gross Profit	$1.780M	$1.360M	$836.5K
YoY Change	25.26%	62.61%	-39.22%
Gross Profit Margin	62.54%	64.52%	67.13%
Selling, General & Admin	$3.009M	$2.969M	$2.275M
YoY Change	18.21%	30.47%	-1.71%
% of Gross Profit	169.03%	218.24%	272.0%
Research & Development	$290.2K	$356.2K	$21.44K
YoY Change	314.53%	1561.44%	170.0%
% of Gross Profit	16.3%	26.19%	2.56%
Depreciation & Amortization	$16.70K	$16.35K	$16.51K
YoY Change	-20.82%	-0.92%	-35.07%
% of Gross Profit	0.94%	1.2%	1.97%
Operating Expenses	$3.321M	$3.341M	$2.313M
YoY Change	26.94%	44.44%	-0.42%
Operating Profit	-$1.541M	-$1.981M	-$1.477M
YoY Change	28.94%	34.14%	55.98%
Interest Expense	-$4.760K	-$4.610K	-$570.00
YoY Change	-170.94%	708.77%	-99.97%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.545M	-$1.986M	-$1.477M
YoY Change	28.33%	34.4%	-48.14%
Income Tax	$0.00	$0.00	$24.72K
% Of Pretax Income
Net Earnings	-$1.122M	-$2.000M	-$1.491M
YoY Change	3.91%	34.14%	-47.44%
Net Earnings / Revenue	-39.42%	-94.87%	-119.65%
Basic Earnings Per Share		-$0.03	-$0.02
Diluted Earnings Per Share	-$16.14K	-$0.03	-$0.02
COMMON SHARES
Basic Shares Outstanding	67.85M	69.57M	65.82M
Diluted Shares Outstanding		69.57M	65.82M

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.76M	$14.49M	$14.45M
YoY Change	3.8%	0.29%	744.35%
Cash & Equivalents	$14.76M	$14.50M	$14.45M
Short-Term Investments
Other Short-Term Assets	$375.4K	$514.4K	$527.1K
YoY Change	-9.75%	-2.4%	-5.84%
Inventory	$1.542M	$1.677M	$2.230M
Prepaid Expenses
Receivables	$943.3K	$968.1K	$963.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.93M	$19.16M	$18.89M
YoY Change	2.04%	1.42%	228.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.71K	$27.14K	$31.31K
YoY Change	-22.83%	-13.32%	-43.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$24.15K	$24.15K
YoY Change	0.0%	0.0%	-32.74%
Total Long-Term Assets	$876.0K	$918.2K	$1.054M
YoY Change	-13.83%	-12.87%	116.51%
TOTAL ASSETS
Total Short-Term Assets	$18.93M	$19.16M	$18.89M
Total Long-Term Assets	$876.0K	$918.2K	$1.054M
Total Assets	$19.81M	$20.08M	$19.95M
YoY Change	1.22%	0.66%	219.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$780.4K	$743.9K	$666.1K
YoY Change	61.59%	11.68%	-9.95%
Accrued Expenses	$1.417M	$1.336M	$1.148M
YoY Change	71.9%	16.39%	64.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$276.2K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$8.550K	$8.350K	$7.900K
YoY Change	9.62%	5.7%
Total Short-Term Liabilities	$3.097M	$3.529M	$3.494M
YoY Change	7.62%	1.01%	-54.31%
LONG-TERM LIABILITIES
Long-Term Debt	$20.06K	$22.27K	$30.62K
YoY Change	-29.88%	-27.27%
Other Long-Term Liabilities	$477.0K	$497.9K	$576.4K
YoY Change	-14.52%	-13.62%
Total Long-Term Liabilities	$497.0K	$520.2K	$607.0K
YoY Change	-15.27%	-14.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.097M	$3.529M	$3.494M
Total Long-Term Liabilities	$497.0K	$520.2K	$607.0K
Total Liabilities	$3.594M	$4.049M	$4.101M
YoY Change	3.75%	-1.26%	-46.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$107.7M	-$106.6M	-$99.81M
YoY Change	6.76%	6.79%	10.09%
Common Stock	$125.0M	$123.7M	$116.6M
YoY Change	5.92%	6.02%	29.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K	$911.5K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K	$33.33K
Shareholders Equity	$16.37M	$16.16M	$15.92M
YoY Change
Total Liabilities & Shareholders Equity	$19.81M	$20.08M	$19.95M
YoY Change	1.22%	0.66%	219.51%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$1.122M	-$2.000M	-$1.491M
YoY Change	3.91%	34.14%	-47.44%
Depreciation, Depletion And Amortization	$16.70K	$16.35K	$16.51K
YoY Change	-20.82%	-0.92%	-35.07%
Cash From Operating Activities	-$388.5K	-$1.559M	-$2.235M
YoY Change	-39.17%	-30.25%	242.0%
INVESTING ACTIVITIES
Capital Expenditures	$4.300K	-$6.410K	-$5.940K
YoY Change		7.91%	226.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$4.300K	-$6.410K	-$5.940K
YoY Change		7.91%	226.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	657.9K	78.54K	79.28K
YoY Change	58.99%	-0.93%	174.61%
NET CHANGE
Cash From Operating Activities	-388.5K	-1.559M	-2.235M
Cash From Investing Activities	4.300K	-6.410K	-5.940K
Cash From Financing Activities	657.9K	78.54K	79.28K
Net Change In Cash	273.6K	-1.487M	-2.161M
YoY Change	-221.61%	-31.22%	245.06%
FREE CASH FLOW
Cash From Operating Activities	-$388.5K	-$1.559M	-$2.235M
Capital Expenditures	$4.300K	-$6.410K	-$5.940K
Free Cash Flow	-$392.8K	-$1.552M	-$2.229M
YoY Change	-38.5%	-30.35%	242.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	67845930
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67610864
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67577531
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	431917	USD
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-51253	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64171435
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64138102
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3178202	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17008818	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
	us-gaap	Open Tax Year OpenTaxYear	2017 2018 2019 2020
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14490745	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14223917	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	968107	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1080656	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	514417	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	415915	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1676532	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	2420179	USD
CY2021Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1509530	USD
CY2020Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	414202	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	19159331	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18554869	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27139	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30729	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	295189	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	329249	USD
CY2021Q3	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	571678	USD
CY2020Q4	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	632453	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150	USD
CY2021Q3	us-gaap	Assets Assets	20077487	USD
CY2020Q4	us-gaap	Assets Assets	19571450	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	743879	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	482972	USD
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	420251	USD
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	385138	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1335755	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	824454	USD
CY2021Q3	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	535481	USD
CY2020Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	586734	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8351	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7796	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	78476	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	72031	USD
CY2021Q3	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	407050	USD
CY2020Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	242589	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	276180	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3529243	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2877894	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22273	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28607	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	497932	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	557981	USD
CY2021Q3	us-gaap	Liabilities Liabilities	4049448	USD
CY2020Q4	us-gaap	Liabilities Liabilities	3464482	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	67610	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	64171	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	123590412	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117934696	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106582501	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100885957	USD
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	911516	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	16164005	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	16201394	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	-135966	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-94426	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16028039	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16106968	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20077487	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19571450	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2108233	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1246110	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7458678	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3225170	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	747997	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	409621	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2926794	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1024947	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	1360236	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	836489	USD
	us-gaap	Gross Profit GrossProfit	4531884	USD
	us-gaap	Gross Profit GrossProfit	2200223	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2968625	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2275274	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9729594	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8146498	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	356179	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21438	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	588043	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	237089	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16353	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16505	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52113	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	74861	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3341157	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2313217	USD
	us-gaap	Operating Expenses OperatingExpenses	10369750	USD
	us-gaap	Operating Expenses OperatingExpenses	8458448	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1980921	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1476728	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5837866	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6258225	USD
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4608	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-569	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11604	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8727	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	276180	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1985529	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1490989	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5696544	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6257668	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1477297	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5573290	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6266952	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24717	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	333	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26217	USD
CY2021Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1985529	USD
CY2020Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1502014	USD
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5573623	USD
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6293169	USD
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-69905	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-164461	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2055434	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-1502014	USD
	us-gaap	Profit Loss ProfitLoss	-5738084	USD
	us-gaap	Profit Loss ProfitLoss	-6293169	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12227	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11025	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-41540	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35501	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2043207	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69573795
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65817132
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68609143
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56478151
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69573795
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65817132
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68609143
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56478151
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16106968	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113507	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	690190	USD
CY2021Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	100000	USD
CY2021Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3012216	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-985857	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19037089	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	193824	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000	USD
CY2021Q2	mlss	Stock To Be Issued During Period Value Issued For Services StockToBeIssuedDuringPeriodValueIssuedForServices	262683	USD
CY2021Q2	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	138200	USD
CY2021Q3	mlss	Stock To Be Issued During Period Value Issued For Services StockToBeIssuedDuringPeriodValueIssuedForServices	227845	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	80512	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2696793	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17568170	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	191946	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2055434	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16028039	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30715	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15012	USD
CY2020Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	171046	USD
CY2020Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	230362	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1612953	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487829	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23946	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000	USD
CY2020Q2	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	462504	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4626442	USD
CY2020Q2	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	718650	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18392	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000	USD
CY2020Q3	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	9602	USD
CY2020Q3	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	36751	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-1502014	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15844590	USD
	us-gaap	Depreciation Depreciation	23076	USD
	us-gaap	Depreciation Depreciation	35103	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	34060	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39759	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	499276	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	76611	USD
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	748658	USD
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	768463	USD
	mlss	Expenses Paid Stock ExpensesPaidStock	490614	USD
	mlss	Expenses Paid Stock ExpensesPaidStock	644865	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-164461	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-0	USD
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	7172	USD
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	30175	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	276180	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-112549	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-747682	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11755	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-743647	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	609251	USD
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	1095328	USD
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	12422	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	98501	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7996	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-260905	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	713331	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	35113	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-965662	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	510790	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3629025	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6346160	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19486	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21438	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19486	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21438	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3150416	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	985763	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5779	USD
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-530659	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4998	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	770702	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	276180	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18043284	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3915339	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19300229	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	266828	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12932631	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14223917	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1516272	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14490745	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14448903	USD
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	0	USD
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-706071	USD
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	0	USD
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	706071	USD
CY2021Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60	pure
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106582501	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5700000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14500000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	300000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b><em style="font: inherit;">3.</em> Reclassifications</b></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b> </b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;">Certain reclassifications have been made to the <em style="font: inherit;">2020</em> unaudited condensed consolidated financial statements to conform to the <em style="font: inherit;">2021</em> unaudited condensed consolidated financial statement presentation. These reclassifications had <em style="font: inherit;">no</em> effect on net loss or cash flows as previously reported.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b><em style="font: inherit;">4.</em> Use of Estimates</b></p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</p> <p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p>
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	13100000	USD
CY2021Q3	us-gaap	Short Term Investments ShortTermInvestments	14300000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	279973	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000	USD
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	450000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	453000	USD
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y1M6D
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012	USD
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	6459000
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	2.01
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P3Y
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	1133975
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.87
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7674239
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7477171
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	92748	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	331711	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1676532	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	2420179	USD
CY2021Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	1509530	USD
CY2020Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	414202	USD
CY2021Q3	mlss	Equity Method Investment Deferred Intercompany Profit Loss EquityMethodInvestmentDeferredIntercompanyProfitLoss	407000	USD
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod	-0
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1088192	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice	0
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.57
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod	-0
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice	0
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4364470
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.15
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P1Y9M3D
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1082674	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	295189	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1048614	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	329249	USD
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6369396
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.97
CY2020	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y5M23D
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2784117	USD
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	0
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	2004926
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6399196
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.95
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y8M23D
CY2020Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	880449	USD
CY2020Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2428329
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2375762
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	33238
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	363956
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	455906
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	387991
CY2021Q3	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2005661
CY2020Q3	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2351727
	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2108233	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1246110	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7458678	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3225170	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1980921	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1476728	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5837866	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6258225	USD
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16353	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16505	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	52113	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74861	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1985529	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1477297	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5573290	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6266952	USD
CY2021Q3	us-gaap	Assets Assets	20077487	USD
CY2020Q4	us-gaap	Assets Assets	19571450	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2108233	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1246110	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7458678	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3225170	USD
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05	pure
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	571678	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	576408	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	78476	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	497932	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	30624	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8351	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22273	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	632453	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	630012	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	72031	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	557981	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	36403	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7796	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28607	USD
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	31882	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	30820	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	95645	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	78904	USD
CY2021Q3	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2658	USD
CY2020Q3	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2685	USD
	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	8055	USD
	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	76622	USD
CY2021Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009	USD
CY2021Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2021Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M18D
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025	pure

Files In Submission

Name	View Source	Status
0001437749-21-026507-index-headers.html	Edgar Link	pending
0001437749-21-026507-index.html	Edgar Link	pending
0001437749-21-026507.txt	Edgar Link	pending
0001437749-21-026507-xbrl.zip	Edgar Link	pending
ex_284638.htm	Edgar Link	pending
ex_284639.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlss-20210930.xsd	Edgar Link	pending
mlss-20210930_cal.xml	Edgar Link	unprocessable
mlss-20210930_def.xml	Edgar Link	unprocessable
mlss-20210930_lab.xml	Edgar Link	unprocessable
mlss-20210930_pre.xml	Edgar Link	unprocessable
mlss20210930_10q.htm	Edgar Link	pending
mlss20210930_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2021 Q4 Form 10-Q Financial Statement

#000143774921026507 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2021 Q4 Form 10-Q Financial Statement

#000143774921026507 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss